Veracyte Stock (NASDAQ: VCYT) stock price, news, charts, stock research, profile.
Open | $21.700 |
Close | $22.160 |
Volume / Avg. | 614.310K / 626.285K |
Day Range | 21.560 - 22.350 |
52 Wk Range | 19.520 - 30.520 |
Market Cap | $1.664B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | - |
Days to Cover | 5.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Veracyte (NASDAQ: VCYT) through any online brokerage.
Other companies in Veracyte’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA) and Day One Biopharmaceutical (NASDAQ:DAWN).
The latest price target for Veracyte (NASDAQ: VCYT) was reported by Morgan Stanley on Monday, February 26, 2024. The analyst firm set a price target for 21.00 expecting VCYT to fall to within 12 months (a possible -5.23% downside). 10 analyst firms have reported ratings in the last year.
The stock price for Veracyte (NASDAQ: VCYT) is $22.16 last updated Today at March 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Veracyte.
Veracyte’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Veracyte.
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.